# NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye

> **NCT00739349** · PHASE2 · COMPLETED · sponsor: **Santen SAS** · enrollment: 132 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** NOVA22007 ''Cyclosporine''
- **DRUG:** NOVA22007 ''Cyclosporine''
- **DRUG:** vehicle/placebo

## Key facts

- **NCT ID:** NCT00739349
- **Lead sponsor:** Santen SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2016-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739349, "NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00739349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*